OncoGenex Pharmaceuticals Inc. Hits New 52-Week Low at $8.27 (OGXI)
Shares of OncoGenex Pharmaceuticals (NASDAQ:OGXI) hit a new 52-week low during trading hours on Wednesday, AnalystRatings.NET reports. The company traded as low as $8.27 and last traded at $8.57, with a volume of 63,939 shares trading hands. The stock had previously closed at $8.51.
Separately, analysts at Stifel Nicolaus cut their price target on shares of OncoGenex Pharmaceuticals from $30.00 to $26.00 in a research note to investors on Friday, August 9th. They now have a “buy” rating on the stock.
OncoGenex Pharmaceuticals has a 1-year low of $8.35 and a 1-year high of $14.28. The stock has a 50-day moving average of $9.06 and a 200-day moving average of $9.80. The company’s market cap is $124.8 million.
OncoGenex Pharmaceuticals, Inc (NASDAQ:OGXI) is a biopharmaceutical company engaged in the development and commercialization of new cancer therapies that address treatment resistance in cancer patients.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.